MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.semarthrit.2011.05.005

Медицинская библиотека · Seminars in arthritis and rheumatism · 2011

New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases.

Wendling Daniel, Paccou Julien, Berthelot Jean-Marie, Flipo René-Marc, Guillaume-Czitrom Séverine, Prati Clément, Dernis Emmanuelle, Direz Guillaume, Ferrazzi Véronique, Ristori Jean-Michel, CRI

СтатьяПеревод в очереди

Аннотация

UNLABELLED: Uveitis may be associated with various inflammatory diseases. Previous reports suggested that tumor necrosis factor (TNF) blockers, especially anti-TNF monoclonal antibodies, may reduce the incidence of uveitis flares in some inflammatory diseases. Under these circumstances, de novo occurrence, ie, new onset of the first episode of uveitis under anti-TNF therapy, is uncommon.

OBJECTIVES

The aim of this study was to collect cases of new onset of uveitis under anti-TNF therapy, using a nationwide network, to describe these cases, and to gather with cases reported in the literature.

METHODS

All French rheumatologists, pediatric rheumatologists, and internal medicine practitioners registered on the Club Rhumatismes et Inflammation web site were contacted in an attempt to declare the cases of new onset of uveitis, diagnosed by an ophthalmologist, in patients treated with TNF blockers. The analysis of the literature was performed through PubMed database and manual research.

RESULTS

Thirty-one cases were recorded, 19 men, mean age 43 (5-70) years, occurring in ankylosing spondylitis (19 cases), psoriatic arthritis (4 cases), rheumatoid arthritis (6 cases), juvenile idiopathic arthritis (2 cases). The TNF blocker at the time of uveitis was etanercept 23 times, adalimumab 3 times, infliximab 5 times, with a mean total duration of exposure to anti-TNF agents of 27 (4-96) months at uveitis occurrence. Most of the patients were good responders to TNF blockers at the time of uveitis onset. Analysis of the literature revealed 121 similar cases published in English.

CONCLUSION

Uveitis occurs de novo under anti-TNF therapy mainly in spondyloarthropathies, but also in rheumatoid arthritis and juvenile idiopathic arthritis patients and more frequently under etanercept.

Для цитирования: Wendling Daniel, Paccou Julien, Berthelot Jean-Marie, Flipo René-Marc, Guillaume-Czitrom Séverine, Prati Clément, Dernis Emmanuelle, Direz Guillaume, Ferrazzi Véronique, Ristori Jean-Michel, CRI. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases.. Seminars in arthritis and rheumatism. 2011. DOI: 10.1016/j.semarthrit.2011.05.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.